Although the incidences were relatively low, hyperplasias of the renal pelvis and the urinary bladder have been observed in Fischer-344 (F-344) rats after both sodium aspartate and glycine treatments in long-term 2-yr bioassays. In the present study, the effects of these amino acids on development of N -butyl-N -(4-hydroxybutyl)nitrosamine (BBN)-initiated urinary lesions were investigated in male and female F-344/DuCrj rats. F-344 rats of both sexes, 6 wk old at the commencement, were given 0.05% BBN for 4 wk and then treated with one of the amino acids at a level of 5.0% in the drinking water for the following 36 wk. Proliferative lesions in the renal pelvis often associated with necrosis and mineralization were increased in the group treated with BBN followed by sodium aspartate, but not by glycine, in both sexes. The same group demonstrated higher incidences of urinary bladder tumors with increased urinary pH and sodium concentration and decreased creatinine and uric acid, but not accompanying crystallization. These results showed a clear promoting effect of sodium aspartate for urinary carcinogenesis in rats. The mechanisms of the effect on the renal pelvis and urinary bladder might be different.
INTRODUCTION
The lower urinary tract is lined by a multilayered epithelium, the transitional epithelium or urothelium, and comprises the renal pelvis, ureter, urinary bladder, and urethra. Experimental animal models of chemical carcinogenesis in the urinary tract have advanced our understanding of human cancer. Transitional epithelial cells normally have a very low mitotic index in the postweaning animal but readily respond to stimuli, such as crystals and chemicals within the urine, by increasing cell division (1, 20) . Therefore, attempts to induce neoplasms in the urinary tract have been relatively successful. In particular, the urinary bladder is the most susceptible organ of the lower urinary tract, because of its storage function and longer exposure time to urinary toxicants (7) . N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) has been shown to possess potent carcinogenicity for the urinary bladder of rats, mice, and dogs (14, 17, 24) . Because spontaneous neoplasms of the rodent urinary tract are rare (26) , BBN has been applied as an appropriate car-cinogen in experimental animal models for urinary tract tumorigenesis. It is a metabolite of the symmetric dibutyl nitrosamine (DBN), and in rats and mice both are urinary bladder carcinogens, with BBN being more specific than DBN in targeting the transitional epithelium (12, 23) . Using BBN-induced tumor models, numerous chemicals have been studied for their risk potential regarding urinary carcinogenesis (8) .
Recently, amino acids and related substances have been widely used as components of processed food. Although some of them were authorized as food additives, the available toxicologic data are limited. Therefore, we earlier conducted subacute and chronic 100-108-wk long-term tests of amino acids including glycine and sodium aspartate (18, 19) . Urinary bladder papillomas were found in 6% of female rats fed 5.0% glycine, whereas proliferative lesions such as hyperplasia were found at incidences of 22-24% in the renal pelvis and 8-12% in the urinary bladder in both sexes of Fischer-344 (F-344) rats fed 5.0% sodium aspartate. The results suggest that these amino acids may have promoting activity for the urinary tract; therefore, the present investigation of their effects on BBN-initiated carcinogenesis was performed. 
MATERIALS AND METHODS
Chemicals and Animals. The BBN used as the carcinogen was purchased from Nakarai Chemicals Ltd. (Kyoto, Japan) and added at a concentration of 0.05% to the drinking water. The test chemicals, glycine and sodium aspartate (monosodium L-aspartate), were obtained from Yuhkigosei Yakuhin Kogyo Co., and Ajinomoto Co. (Kanagawa, Japan), respectively. Both amino acids were given at 5.0% in the drinking water. The dose and the treatment were determined by our previous studies (18, 19) . A total of 100 male and 100 female F-344/DuCrj rats were obtained at 5 wk of age from Charles River Co. Japan Inc. (Kanagawa, Japan). They were maintained on basal diet (CRF-1, Charles River Co.) for 1 wk and then randomly allocated to 6 groups for each sex. The rats were housed in plastic cages (40 X 25 X 18 cm, 3/cage) and maintained in an air-conditioned room at 24 ± 2°C with a relative humidity of 55 ± 5% and a 12-hr light-dark cycle. Feed and drinking water with or without chemicals were freely available.
Experimental Design. Starting at 6 wk of age, Groups 1-3 received 0.05% BBN in the drinking water for 4 wk, while Groups 4-6 were given water without supplement. From the end of experimental week 4 (10 wk of age), Groups 1 and 4 received 5.0% glycine in the drinking water; Groups 2 and 5 similarly received 5.0% sodium aspartate, and Groups 3 and 6 were given water as controls. All surviving animals were sacrificed at week 40. Urine was collected for 24 hr from 5 representative rats in each group before sacrifice. Blood from the same rats was obtained from the abdominal aorta under anesthesia, with sacrifice being performed by exsanguination for subsequent pathological examination of tumor development. The blood and urine biochemistry was determined using OLYMPUS AU5200, dicrete twin reaction lines and ISE (Olympus, Tokyo).
Pathology. Five randomly selected rats from each group were given a single ip injection of 100 mg/kg body weight of bromodeoxyuridine (BrdU; Sigma Chemical Co., St. Louis, MO, USA) 1 hr prior to sacrifice. Individual whole-body, liver, and kidney weights were recorded at necropsy. The kidneys, urinary bladders, and small intestines from BrdU-treated rats were fixed in 70% ethanol for 24 hr and processed using the avidin-biotin peroxidase complex technique for immunohistochemical demonstration of DNA synthesis. Tissues from the remaining animals were preserved in 10% neutral-buffered formalin. The urinary bladders were inflated with 10% buffered formalin by intraluminal injection. After processing and embedding in paraffin, tissues were sectioned at 5 /-1m and stained with hematoxylin and eosin for histological evaluation. Proliferative lesions in the renal pelvis and urinary bladder were classified into the following categories (16) : simple hyperplasia consisting of diffuse or focal thickening of the epithelium with 4-8 layers of transitional epithelial cells; papillary or nodular hyperplasia (PN hyperplasia), with epithelium 6-8 cells thick, in most cases strictly localized, rare cellular atypia, and mitotic figures; papillomas, defined as benign epithelial tumors with transitional epithelial cells arranged in branched fingerlike processes or showing an endophytic growth pattern; and carcinomas demonstrating a high degree of mitotic activity and invasion into the muscularis.
The number of lesions per 1 cm basement membrane was observed by using an objective micrometer (Olympus). Calcification was observed by light microscopy, and the representative sections were stained with von Kossa. Quantitative data were analyzed for statistical significance via the Student's t-test and Fisher's exact test.
RESULTS
The numbers of male rats surviving to the study termination were 15/20 (75%) in Group 2 and 16/20 (80%) in Group 5, whereas the figure was 100% in glycine treatment Groups 1 and 4. On the other hand, only a single female rat in both Groups 2 and 3 died during the experiment (Table I ). There were no specific findings in such animals at autopsy. The cause of death might be malnutrition due to the toxic effects and unbalanced electrophoresis, particularly abnormal sodium and potassium concentrations.
The results of serum and urine analysis are shown in Tables II and III . Biochemistry values demonstrated similar tendencies for both males and females, with statistically significant decreases in the sodium aspartate treatment groups being observed for alkaline phosphate and triglyceride in the serum and urea nitrogen (BUN), creatinine, and uric acid in the urine. Significant decreases were noted in BUN and uric acid in the blood. Urinary pH and sodium concentration were significantly elevated in Group 2. No specific findings were observed for glutamic-oxaloacetic transaminase, glutamic pyruvic transaminase, lactic dehydrogenase, creatinine phosphokinase, total cholesterol, and electrolytes in either sex, except for a lower value (approximately half) for potassium in Group 2.
The relative kidney-to-body weight ratios at 40 exper- Significantly different from Group 6 (p < 0.05). b Significantly different from Group 3 (p = 0.051).
imental wk in the amino acid treatment groups were significantly higher than in the untreated controls in both sexes (Table I ). The incidences of proliferative lesions in the renal papillae are compared in Tables IV and V. In male rats, simple hyperplasia was found in all groups; however, the incidences in the sodium aspartate treatment group were significantly increased over the untreated control values. Sodium aspartate treatment increased the incidence of PN hyperplasia over the BBN-alone group (p = 0.051). Mineralization and necrotic changes were often observed in association in groups administered with sodium aspartate (Fig. 1 ). Incidences and the number per 1 cm basement membrane data for proliferative lesions observed in urinary bladder are summerized in Tables VI and VII. Simple hyperplasias were observed in Groups 1-5, whereas PN hyperplasias and tumors were only apparent in groups treated with BBN. Both sexes in Group 2 showed higher incidences of hyperplasias, papilloma, and carcinomas, and had larger numbers of the lesions than Group 3 (Figs. 2 and 3 ). In particular, the incidences of carcinomas in both sexes were significantly higher than the Group 3 values. No promoting effects were observed in the glycine treatment group. The number of BrdU-labeled cells counted per 500 cells was recorded.
BrdU-labeled cells were rare in normal urothelium, and only 1-2 labeled cells were observed in areas of simple hyperplasia. The mean numbers of labeled cells per 500 cells were 20, 45, and 64 in PN hyperplasia, papilloma, and carcinoma, respectively (Fig. 4a, b ). The labeling indices were dependent on the various categories of proliferative lesions, not on the treatment.
DISCUSSION
The finding that long-term administration of glycine and sodium aspartate to weaning male and female F-344 rats produced proliferative lesions in the urinary system is rationale for the present examination of whether or not these amino acids might exert promoting effects on BBN-initiated lesion development. The results demonstrated a clear positive influence of sodium aspartate on urinary bladder tumors and preneoplastic lesions in both sexes. While no tumors were observed in the renal pelvis, the incidences of proliferative lesions were also increased by the sodium aspartate treatement. Spontaneous neoplasias of the rat urinary system are rare (26) , and both naturally occurring and induced proliferative lesions in the renal papillae, ureter, and urethra are infrequent (7, 8) . The reason for the lack of proliferative lesions at these sites may be that urine containing toxicants passes through them quickly as compared to the more lengthy contact in the urinary bladder.
The concept of 2-stage carcinogenesis is now well established for many organs, including those in the urinary tract (2, 5) . Since the original finding that sodium saccharin increases the incidence of bladder tumors in rats when given chronically (15) , Fukushima et al. have reported various chemicals to be tumor promoters of bladder tumor development in rats (9) . Amino acids such as DL-tryptophan, L-leucine, and L-isoleucine have promoting activities on urinary bladder carcinogenesis in rats (9) . However, sodium aspartate had not been reported to induce bladder tumors or proliferative lesions in renal pelvis. Our previous studies of long-term exposure to glycine and sodium aspartate demonstrated production of organ-specific lesions in the urinary system in a dose-related fashion in both sexes of rats (18, 19) . Only sodium aspartate had a promoting effect following initiation by BBN to F-344 rats in the present study. The mechanism for the promoting effect of sodium aspartate might be linked to the sodium salts (4, 6) .
In the induction of transitional cell tumors, it is important to understand the influence of calcali, crystalluria, urinary pH, and other physical factors. We have previously shown that phytic acid induces necrosis of the renal pelvis as well as papillomas in rats (13) . Although urinary pH greatly influences urothelial proliferation, necrosis and mineralization could play a more important role in the proliferative response, especially in the renal papillae. Hyperplastic lesions in glycine treatment groups, 1. -Hyperplasia with necrosis and calcification (arrow) in the renal pelvis in the rat treated with aspartate (Group 5). H&E.
X40. albeit at a low incidence, could be observed even at low urinary pH.
Of interest in the present investigation were the very high urinary pH and increased sodium concentration in the group given BBN followed by sodium aspartate and the strong promotion of urinary bladder tumor development. These results suggest that the mechanism of proliferative responses may differ between the renal pelvis and the urinary bladder. Urinary pH is probably the most critical parameter for evaluating mechanisms of cell proliferation and/or carcinogenesis in the urinary bladder. In addition, increased sodium concentration associated with high urinary pH in the urine plays an important role in the promotion of 2-stage urinary bladder carcinogenesis in rats (10) . With sodium salt administration, the mech- anism by which urinary pH affects the urothelial response is not completely clear, but the hypothesis has been formulated that a high urinary pH enhances the formation of precipitate or crystalline materials (3) . There are a number of cases, however, without crystallization in urinary bladder at high urinary pH, as in the present study. Increased pH is a known factor related to increased cell proliferation in tissue culture (27) and enhances the affinity of epidermal growth factor (EGF) for its specific membrane receptor (21) . Thus, pH could stimulate cell proliferation simply by enhancing the binding of EGF to its receptor.
Although it is unclear why a high urinary pH resulted with sodium aspartate, but not glycine treatment, this may be due to the different metabolism in the kidney. The metabolism of aspartate is initiated by transamination with a-ketoglutarate, followed by oxidative deamination of the resulting glutamate to regenerate the keto acid. In the absence of added a-ketoglutarate in the perfused rat kidney, the nitrogen of glycine appears entirely as ammonia, whereas that of aspartate appears as glutamate and glutamine (25) . While there is no direct evidence that other factors observed to be charged in the present study, such as abnormal BUN, creatinine and uric acid, play a role in urinary carcinogenesis, creatinine and urea have been suggested to interact or modulate carcinogenesis (11, 22) . Although we did not evaluate calcium phosphate precipitate in the urine treated with sodium aspartate, the precipitated materials might provide a possible indirect mechanism in the carcinogenesis (6) . There are differences between sexes in animals, particularly with respect to the hormones and the urinary protein (3) ; however, the incidences of the lesions in the urinary bladder between male and female showed no significant difference. Sodium aspartate treatment yielded preneoplastic lesions in the male renal pelvis, more than those in females, with calcification. In our results, the renal pelvis of male rats was slightly susceptible to the test chemicals examined. However, hormonal factors may be less important for the urinary carcinogenesis in rats.
Because many urinary bladder lesions in humans are similar in both morphology and behavior to those induced in rats, the use of experimental models is widely accepted. The fact that the processes involved in urothelial carcinogenesis frequently involve a complex interaction of multiple variables, such as urinary pH, cationic or anionic concentration, and generation of precipitates, crystals, or calculi, validates the experimental approach.
The present results confirm that the amino acid sodium aspartate has a promoting effect on urinary carcinogenesis in both the renal papillae and urinary bladder of rats. The mechanisms operating in these 2 sites may differ; that is, necrosis and calcification might be more important in the renal pelvis case, whereas urinary pH with increased sodium concentration, which may be due to the sodium salts, is of greater significance for urinary bladder tumorigenesis.
